Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode Psychosis
出版年份 2017 全文链接
标题
Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode Psychosis
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-05-17
DOI
10.1038/s41598-017-02267-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression
- (2016) Molly A. Erickson et al. BIOLOGICAL PSYCHIATRY
- Mismatch Negativity in First-Episode Schizophrenia
- (2016) Sarah M. Haigh et al. CLINICAL EEG AND NEUROSCIENCE
- Nature of Glutamate Alterations in Schizophrenia
- (2016) Kate Merritt et al. JAMA Psychiatry
- Unknown
- (2015) Annals of the New York Academy of Sciences
- Forecasting Psychosis by Event-Related Potentials—Systematic Review and Specific Meta-Analysis
- (2015) Mitja Bodatsch et al. BIOLOGICAL PSYCHIATRY
- Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients
- (2015) Rachel A. Hay et al. BIOLOGICAL PSYCHOLOGY
- Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
- (2015) Y Iwata et al. MOLECULAR PSYCHIATRY
- Auditory dysfunction in schizophrenia: integrating clinical and basic features
- (2015) Daniel C. Javitt et al. NATURE REVIEWS NEUROSCIENCE
- Finding the missing-stimulus mismatch negativity (MMN) in early psychosis: Altered MMN to violations of an auditory gestalt
- (2015) Erica D. Rudolph et al. SCHIZOPHRENIA RESEARCH
- Brain disorders? Precisely
- (2015) T. R. Insel et al. SCIENCE
- Targeting of NMDA receptors in new treatments for schizophrenia
- (2014) Kenji Hashimoto EXPERT OPINION ON THERAPEUTIC TARGETS
- Peripheral Glutamate Levels in Schizophrenia: Evidence from a Meta-Analysis
- (2014) Jiali Song et al. NEUROPSYCHOBIOLOGY
- Changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment
- (2014) Hidenaga Yamamori et al. NEUROSCIENCE LETTERS
- A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study
- (2014) S Koike et al. Translational Psychiatry
- Automatic Auditory Processing Deficits in Schizophrenia and Clinical High-Risk Patients: Forecasting Psychosis Risk with Mismatch Negativity
- (2013) Veronica B. Perez et al. BIOLOGICAL PSYCHIATRY
- A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder
- (2013) Kate M. Chitty et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: A meta-analysis of case–control studies
- (2013) Annelies Brouwer et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- LORETA Current Source Density for Duration Mismatch Negativity and Neuropsychological Assessment in Early Schizophrenia
- (2013) Tomohiro Miyanishi et al. PLoS One
- Nonhuman primate model of schizophrenia using a noninvasive EEG method
- (2013) R. Gil-da-Costa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis
- (2013) Tatsuya Nagai et al. SCHIZOPHRENIA RESEARCH
- Mismatch Negativity as a “Translatable” Brain Marker Toward Early Intervention for Psychosis: A Review
- (2013) Tatsuya Nagai et al. Frontiers in Psychiatry
- Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
- (2012) D. C. Javitt et al. SCHIZOPHRENIA BULLETIN
- Capturing the Angel in "Angel Dust": Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans
- (2012) B. Moghaddam et al. SCHIZOPHRENIA BULLETIN
- A multimodal approach to investigate biomarkers for psychosis in a clinical setting: The integrative neuroimaging studies in schizophrenia targeting for early intervention and prevention (IN-STEP) project
- (2012) Shinsuke Koike et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia shows a unique metabolomics signature in plasma
- (2012) Y He et al. Translational Psychiatry
- Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments
- (2011) André Schmidt et al. NEUROPSYCHOPHARMACOLOGY
- Prediction of Psychosis by Mismatch Negativity
- (2010) Mitja Bodatsch et al. BIOLOGICAL PSYCHIATRY
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
- (2010) Joshua T. Kantrowitz et al. BRAIN RESEARCH BULLETIN
- Glycine serum level in schizophrenia: Relation to negative symptoms
- (2010) Jaromir Hons et al. PSYCHIATRY RESEARCH
- Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review
- (2008) Risto Näätänen et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Changes in plasma glycine, l-serine, and d-serine levels in patients with schizophrenia as their clinical symptoms improve: Results from the Juntendo University Schizophrenia Projects (JUSP)
- (2008) Tohru Ohnuma et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Deviant Matters: Duration, Frequency, and Intensity Deviants Reveal Different Patterns of Mismatch Negativity Reduction in Early and Late Schizophrenia
- (2007) Juanita Todd et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now